Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GENALICE Prepares for Launch of Raw DNA Sequence Data Processing Software

Published: Friday, April 19, 2013
Last Updated: Friday, April 19, 2013
Bookmark and Share
Management team realignment.

GENALICE B.V. has announced the imminent release of the beta version of its first product, GENALICE MAP, to take place within the next few weeks.

MAP can process raw DNA data, produced by sequencers, in a fast, cost effective and reliable way and stores the data in a small file for easier manageability.

Major applications are DNA research and drug development of complex diseases such as cancer. In anticipation of this new phase of the company’s development the tasks within the management team have been rearranged.

Jos Lunenberg will now fulfill the role of CEO (Chief Executive Officer). Bert Reijmerink will now assume the position of CSO (Chief Strategy Officer). Co-founder Hans Karten remains CTO (Chief Technology Officer).

New phase, new organization
The management of GENALICE is passionate about contributing to improving the diagnosis and treatment methods for patients with complex DNA-related diseases.

The company was founded in 2011 by Bert Reijmerink and Hans Karten, who is highly experienced in the field of ‘high performance’, ‘high volume’ data processing and analysis.

In January last year, the team was strengthened by the arrival of Jos Lunenberg, an expert in marketing & sales management and business strategies within the life sciences industry.

In the initial phase of GENALICE the focus was on developing new products and finding investors. To this end, alliances were sought with scientists and managers from the top of the medical community and industry.

Consequently the launch of GENALICE’s first product is now imminent.

For a photo of Jos Lunenberg, CEO GENALICE (photographer: Bart Dykstra) please click this link: http://www.genalice.com/wp-content/uploads/2013/04/GEN-36-JL.jpg

"We believe we can bring a major breakthrough in DNA research with our product"
"GENALICE MAP can process raw data, produced by sequencers, rapidly, cost effectively and reliably," explains Hans Karten about the new product. "MAP accelerates this so-called alignment process two hundred-fold compared to existing methods. The required disk space for storing the data is a hundred times smaller than is common. Earlier this week we presented these breakthrough results at the annual Netherlands Bioinformatics Conference (NBIC 2013)".

Bert Reijmerink adds: "This gives scientists the opportunity for cheaper and faster DNA research and new drug development to tackle complex diseases such as cancer. The energy savings that we can realize are significant too. With the launch of MAP - in the summer of this year - we can bring about a major breakthrough in DNA research. For this phase we needed another type of CEO; one with knowledge and experience in the field of life sciences and healthcare. With his background as a molecular biologist and his broad and international experience in the life sciences industry, Jos Lunenberg is a logical choice. As of today, I will focus on the setting up strategic alliances and indirect sales models, so that we can continue to grow in the near future and develop new products to bring to the market”.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

KeyGene and GENALICE Join Forces
KeyGene purchased a license of GENALICE MAP, a groundbreaking new sequence-mapping tool to accelerate and improve DNA research.
Wednesday, October 30, 2013
GENALICE Prepares For Software Launch with Management Realignment
Company to launch raw DNA sequence data processing software.
Thursday, April 18, 2013
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Rice Disease-Resistance Discovery Closes the Loop for Scientific Integrity
Researchers reveal how disease resistant rice detects and responds to bacterial infections.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!